Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 9, 2007

C-reactive Protein Linked to Risk of Developing AMD

  • High blood levels of C-reactive protein appear to be associated with an increased risk for age-related macular degeneration (AMD), according to Erasmus Medical Center researchers.

    The Erasmus team examined C-reactive protein levels in 4,914 individuals at risk for AMD. At the initial examination, conducted between 1990 and 1993, blood samples were collected and photographs were taken of the retina. Three additional examinations were conducted over an average of 7.7 years.

    During this time, 658 people were diagnosed with AMD, including 561 with early AMD and 97 with late AMD. The scientists found that as an individual’s C-reactive protein level increased above the median of the study population, he or she became more likely to develop AMD.

    The report is published in the October issue of Archives of Ophthalmology.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »